Giulia shocked the world with her WWE debut at NXT No Mercy. The former NJPW star appeared following the NXT Women's Championship match between Roxanne Perez and Jaida Parker. Following her debut ...

Triple H thinks Giulia is a future star in WWE following her debut at NXT No Mercy. At the PLE last night, NXT Women’s Champion Roxanne Perez defended her title against Jaida Parker. She won the ...

Now, she London-born talent brings her skills to NXT. Giulia departed NJPW (New Japan Pro Wrestling) and headed to the United States, having spent her last four years in the overseas promotion.

The couple first shared the news of their engagement on Instagram on Aug. 12, with Giulia Be writing, "Easiest yes of all time" Erin Clack is a Staff Editor for PEOPLE. She has been writing about ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last ...

Also Read | Despite a 134% jump in last 1 year, Elara has a sell call on this defense stock HUL finalized its merger with GlaxoSmithKline Consumer Healthcare Limited (GSKCH) in 2020, after ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

After being in the WWE development facilities for almost a year, Giulia is getting ever so close to her WWE debut, very much ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...